Clinical Trials Directory

Trials / Completed

CompletedNCT02818413

Stool Microbiome, Pathogens, and Infectious Agents Among Olympic and Elite Athletes

TRMC-Bio "Molecular Profiling of Gut Microbiome, Microbiome Metabolome, Serum Chemistry, and Metabolism-Associated SNPs in Elite Athletes"

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This research is being done to investigate fecal microbiome and metabolome as well as serum analytes and single nucleotide polymorphisms in Olympic athletes in comparison with other elite athletes.

Detailed description

Olympic athletes, non-Olympic elite athletes, and other active adults may have genetic and metabolic profiles that are unique. These profiles may contribute to the caliber of their athletic performance, and they may provide keys to understanding select genetic and metabolic conditions. Therefore, the specific aims of this project are as follows: * Specific Aim 1: Characterize the fecal microbial communities in athletes participating in the summer 2016 games and in athletes not participating in the Olympic games * Specific Aim 2: Characterize the fecal microbiome metabolome (untargeted) in athletes participating in the summer 2016 games and in athletes not participating in the Olympic games * Specific Aim 3: Characterize selected serum analytes and single nucleotide polymorphisms (SNPs) of elite athletes participating in the Summer 2016 games and in athletes not participating in the Olympic games, via serum and saliva analyses, respectively * Specific Aim 4: Retain specimens from Olympic athletes participating in the summer 2016 games and in athletes not participating in the Olympic games for future research * Specific Aim 7: Examine for the presence of Zika virus RNA in study participants who exhibit symptoms Stool, urine, and blood specimens will be collected to study the stool metabolome, as well as serum analytes and single nucleotide polymorphisms, and the nature and extent of exposure to pathogens and infectious agents. These will be compared between Olympic athletes and other non-Olympic elite athletes.

Conditions

Interventions

TypeNameDescription
OTHERBiospecimen collection and questionnairesBiospecimen collection and questionnaires

Timeline

Start date
2016-06-03
Primary completion
2017-03-21
Completion
2017-03-21
First posted
2016-06-29
Last updated
2017-08-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02818413. Inclusion in this directory is not an endorsement.